Jointly Advancing 100% “Made in Hong Kong” Eco Friendly Antimicrobial Materials Research Driven Innovation Empowering Industrial Upgrading

[Hong Kong, 3 February 2026]

Kin Sang Chemical Ltd. (KSC) today signed a Memorandum of Understanding (MOU) with Immune Materials Limited (IML), a subsidiary of The Hong Kong Polytechnic University (PolyU), and CVI Modern Technology Development Ltd. (CVI). By integrating strengths in scientific research, materials engineering, and industrial networks, the three parties will jointly develop 100% “Made in Hong Kong” eco‑friendly, non‑toxic antimicrobial materials, This collaboration also reflects deeper cross-regional innovation exchange, translating academic research into market-ready solutions into the traditional plastics industry.

The signing ceremony was held at the PolyU campus and was witnessed by Professor Christopher Chao, Senior Vice President (Research and Innovation) of The Hong Kong Polytechnic University. Distinguished guests in attendance included Mr. Fan Yanfeng, the Director of the Hong Kong and Macao Affairs Division, Foreign Affairs Office of Fujian Provincial People's Government, Mr. Wong Wing‑wai, Legislative Council Member of the Functional Constituency - Industrial (First), as well as representatives from mainland government and industry partners—together marking this important milestone.

Collaboration: Connecting Innovation, Engineering, and Market Adoption

This collaboration brings together three representative Hong Kong‑based forces, each excelling in its respective domain:

• IML contributes advanced, eco‑friendly, non‑toxic antimicrobial materials technology originating from The Hong Kong Polytechnic University (with IMU+® as its antimicrobial technology trademark).
• CVI, as the materials engineering and scale‑up partner, focuses on formulation engineering, process optimization, and stable mass production.
• Kin Sang Chemical, leveraging its well‑established supply chain and sales networks across Hong Kong, Mainland China, and overseas markets, directly connects with brand owners and manufacturers to drive real‑world application and commercialization of the new materials.

Mr. Terry Cheng, Executive Director of Kin Sang Chemical, stated that the next stage of development in the materials industry is no longer about competition among individual products, but about the integration and execution of complete solutions. Kin Sang Chemical will fully leverage its sales and supply chain advantages across Hong Kong, Mainland China, and Southeast Asia to accelerate the commercialization of the new generation of Hong Kong‑made eco‑friendly antimicrobial materials, promote their adoption across multiple application scenarios, and create tangible industrial value.

The presence of representatives from research, engineering, market, and industry partners marks an important step in advancing next‑generation antimicrobial materials from scientific innovation to real‑world application and industrialization.

Focus on Diverse Application Scenarios; Debut at CHINAPLAS 2026

The three parties noted that the antimicrobial polymer materials are expected to be applied in medical and care environments, elderly and childcare facilities, and high‑contact public spaces, and further extended to food packaging, toys, and daily consumer products. Through long‑lasting, passive material‑based protection, these solutions offer a more sustainable approach to everyday environmental hygiene management.

Professor Chris Lo, Founder of Immune Materials Limited, introduced and demonstrated applications of the antimicrobial materials in elderly care environments. The product shown is an antimicrobial pillow core protective cover.

Professor Chris Lo also introduced and demonstrated applications of the antimicrobial materials in packaging and consumer goods.

The collaborative R&D result will make its first public debut in April this year at the 38th CHINAPLAS in Shanghai, within the “Innovative Technology Products” zone, showcasing to the international market the latest achievements resulting from the deep integration of Hong Kong innovation and manufacturing.

Immune Materials Limited is a Hong Kong‑based innovative materials technology company founded by professors and research teams from The Hong Kong Polytechnic University. The company focuses on the R&D and commercialization of eco‑friendly antimicrobial materials (IMU+® is its antimicrobial technology trademark). Its core technologies originate from PolyU research and achieve durable, stable antimicrobial performance by embedding antimicrobial functionality directly into the plastics manufacturing process. IML’s solutions are widely applied in medical, public facilities, and daily consumer products, embodying the principle of “research empowering industry.” As the business expands, IML has introduced new team members and established operations in Xiamen this year, actively expanding into the Mainland China market.

Kin Sang Chemical Ltd. is a professional enterprise specializing in chemical products and related solutions. For over half a century, the company has remained committed to providing customers with high‑quality, reliable and competitive products and services. With extensive industry experience and deep technical expertise, Kin Sang has built a solid reputation in the market. Its sales network spans China and Southeast Asia, earning the strong trust of customers and partners alike.

CVI Modern Technology Development Ltd. is a technology‑driven polymer materials solutions provider with roots dating back to 1990. Headquartered in Hong Kong, with manufacturing and R&D facilities in Malaysia, CVI is dedicated to delivering high‑performance masterbatch and modified materials solutions for the plastics industry. Its comprehensive product portfolio includes anti‑fog, slip, anti‑blocking, antistatic, UV‑resistant, and processing additive masterbatches, as well as nylon‑based and other specialty modified compounds, widely used in packaging, films, and engineering plastics.